Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years

Fabio A. Barroso, Daniel P. Judge, Ben Ebede, Huihua Li, Michelle Stewart, Leslie Amass, Marla B. Sultan

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'Long-term safety and efficacy of tafamidis for the treatment of hereditary transthyretin amyloid polyneuropathy: results up to 6 years'. Together they form a unique fingerprint.

Medicine & Life Sciences